Healthcare -
Biotechnology - NASDAQ - US
$ 4.91
-0.607 %
$ 222 M
Market Cap
-7.33
P/E
Price Target
Average
373.52%
Revenue Forecast
Estimate
9.08%
EBIT
Estimate
--30.63%
Net Income
Estimate
--17.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Y-mAbs Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for YMAB of $23.2 , with forecasts ranging from
a
low of
$21 to a high of $26 .
YMAB Lowest Price Target
Wall Street Target
21 USD
327.70%
YMAB Average Price Target
Wall Street Target
23.2 USD
373.52%
YMAB Highest Price Target
Wall Street Target
26 USD
429.53%
REVENUE FORECAST
Revenue Forecast Chart YMAB
EBIT FORECAST
EBIT Forecast Chart YMAB
NET INCOME FORECAST
Net Income Chart YMAB